Hjem › Burkitts lymfom › New York › Syracuse

Kliniske studier for Burkitts lymfom i Syracuse, NY

4 studier for Burkitts lymfom søker deltakere på steder i og rundt Syracuse (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2

State University of New York Upstate Medical University, Syracuse

366 Days – 46 Years · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekruttererFase 2

State University of New York Upstate Medical University, Syracuse

365 Days · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2

State University of New York Upstate Medical University, Syracuse

Alder 1 til 30 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekruttererFase 3

State University of New York Upstate Medical University, Syracuse

365 Days – 25 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03959085

Burkitts lymfom-studier i andre byer

Andre studier i Syracuse

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.